登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Additional file 2 of Transparency and reporting characteristics of COVID-19 randomized controlled trials
Additional file 2 of Transparency and reporting characteristics of COVID-19 randomized controlled trials
收藏
Figshare
2022-09-26 更新
2026-04-28 收录
临床试验元分析
循证医学
数据链接：
https://figshare.com/articles/dataset/Additional_file_2_of_Transparency_and_reporting_characteristics_of_COVID-19_randomized_controlled_trials/21207016
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Additional file 2. List of excluded trials.
应用场景：
创建时间：
2022-09-26
相关数据集
AMSTAR criteria for each study.
系统综述质量评估
循证医学
AMSTAR criteria for each study.
NIAID Data Ecosystem
6
0
Extended thromboprophylaxis in cancer patients who underwent abdominal or pelvic surgery.
术后血栓预防
循证医学
Systematic review protocol registration
DataCite Commons
2020-08-03 更新
2
0
Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) checklist for: Pregnancy and birth complications and long-term adverse maternal mental health outcomes: a systematic review and meta-analysis protocol.
循证医学
围产期心理健康研究
PRISMA-P Checklist PRISMA flow diagram
Figshare
2022-12-05 更新
2
0
Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review
ADHD治疗
循证医学
Background Evaluation of treatments for attention-deficit/hyperactivity disorder (ADHD) previously focused on symptom control, but attention has shifted to functional outcomes. The effect of different
NIAID Data Ecosystem
5
0
GRADE for oral Chinese herbal medicine plus pharmacotherapy versus pharmacotherapy for chronic rhinosinusitis: All studies.
慢性鼻窦炎临床研究
循证医学
GRADE for oral Chinese herbal medicine plus pharmacotherapy versus pharmacotherapy for chronic rhinosinusitis: All studies.
Figshare
2022-12-01 更新
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
